Scilex Holding Co cotiza a 2.88 USD y tiene una capitalización bursátil de $20M. En los últimos 12 meses ha facturado $32M con un margen de flujo de caja libre del 12.2%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain assoc…
| Periodo | 2026-04 | 2026-03 | 2025-11 | 2025-08 |
|---|---|---|---|---|
| Real | $-1.17 | — | $-21.29 | $-7.42 |
| Estimado | $-0.47 | $-0.47 | $-0.41 | $-0.91 |
| Sorpresa | -148.9% | — | -5092.7% | -715.4% |
| Métrica | SCLX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 415.8% | 57.0% | +358.8% |
| Operating Margin | -1143.7% | -38.6% | -1105.1% |
| Net Margin | -1236.4% | -33.6% | -1202.9% |
| FCF Margin | 12.2% | -13.9% | +26.0% |
| ROE | — | -40.4% | — |
| ROA | -102.5% | -32.0% | -70.5% |
| Current Ratio | 0.08 | 2.84 | -2.76 |
| Debt / Equity | -0.13 | 0.28 | -0.41 |